| Scottsbluff Vision Clinic Pc | |
| 3726 Avenue D, Scottsbluff, Nebraska 69361 | |
| (308) 635-1234 |
| Name | Scottsbluff Vision Clinic Pc |
|---|---|
| Organization Name | Scottsbluff Vision Clinic Pc |
| Location | 3726 Avenue D, Scottsbluff, Nebraska 69361 |
| Type | Supplier |
| Phone | (308) 635-1234 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The Board of Directors of Bristol-Myers Squibb Company today declared a quarterly dividend of 32 cents ($0.32) per share on the $0.10 par value Common Stock of the corporation. The quarterly dividend will be payable on August 2, 2010 to stockholders of record at the close of business on July 2, 2010.
The U.S. Army Medical Research Institute of Infectious Diseases today announced that, for the first time, the U.S. Food and Drug Administration has provided formal regulatory agreement for use of an animal model to support development of a drug candidate, remdesivir, for treating deadly Ebola virus infections.
Treating diabetes during pregnancy can break the link between gestational diabetes and childhood obesity, according to a Kaiser Permanente study featured in the September issue of Diabetes Care.
AVEO Pharmaceuticals, Inc. today announced that it has initiated patient enrollment in a multi-center Phase 2 exploratory biomarker study of tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with renal cell carcinoma (RCC).
› Verified 2 days ago
News Archive
The Board of Directors of Bristol-Myers Squibb Company today declared a quarterly dividend of 32 cents ($0.32) per share on the $0.10 par value Common Stock of the corporation. The quarterly dividend will be payable on August 2, 2010 to stockholders of record at the close of business on July 2, 2010.
The U.S. Army Medical Research Institute of Infectious Diseases today announced that, for the first time, the U.S. Food and Drug Administration has provided formal regulatory agreement for use of an animal model to support development of a drug candidate, remdesivir, for treating deadly Ebola virus infections.
Treating diabetes during pregnancy can break the link between gestational diabetes and childhood obesity, according to a Kaiser Permanente study featured in the September issue of Diabetes Care.
AVEO Pharmaceuticals, Inc. today announced that it has initiated patient enrollment in a multi-center Phase 2 exploratory biomarker study of tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with renal cell carcinoma (RCC).
› Verified 2 days ago
Bluffs Vision Care Pc Type: Medicare Supplier Location: 416 Valley View Dr, Scottsbluff, Nebraska 69361 Phone: (308) 635-1633 | |
High Plains Orth & Pros Inc. Type: Medicare Supplier Location: 1930 E. 20th Place, Scottsbluff, Nebraska 69361 Phone: (308) 632-4641 | |
Lincare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 410 S Beltline Hwy W, Scottsbluff, Nebraska 69361 Phone: (308) 632-8309 | |
Orthotic Prosthetic Solutions Type: Prosthetic/Orthotic Supplier Location: 1012 West 36th Street, Scottsbluff, Nebraska 69361 Phone: (720) 652-0100 | |
Safeway Pharmacy #0556 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 601 Broadway, Scottsbluff, Nebraska 69361 Phone: (308) 635-1444 |